A Multicenter, Prospective, Non-interventional, Observational Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of this clinical trial is to evaluate the efficacy and safety of dapagliflozin in patient with type 2 diabetes mellitus and hypertension
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Those diagnosed with type 2 diabetes mellitus accompanied by hypertension who are scheduled to be administrated Trudapa Tab. or Trudapa M SR Tab.
• Those who voluntarily signed a written personal information agreement to participate in this clinical study.
• Those able to understand this study, be cooperative in the execution of the study, and participate in the study until its completion.
Locations
Other Locations
Republic of Korea
Gachon University Gil Medical Center
RECRUITING
Incheon
Contact Information
Primary
Shinyoung Oh
syoh@boryung.co.kr
+82-2-708-8000
Time Frame
Start Date: 2023-07-26
Estimated Completion Date: 2025-10-21
Participants
Target number of participants: 9000
Related Therapeutic Areas
Sponsors
Leads: Boryung Pharmaceutical Co., Ltd